All supplements

Supplement evidence

090 / 575Mood & stress

St. John’s wort

View my plan

The short answer

Standardized extracts can improve mild-to-moderate depressive symptoms, but interaction risk is unusually high.

Evidence and scope
Supported for specific outcomes

This status does not grade the ingredient for every goal, outcome, or person.

Important limitation
Evidence supports a specific outcome, not a general wellness or longevity effect.
Before deciding
Key concern: Do not combine with antidepressants, birth control, transplant, HIV, anticoagulant, seizure, cancer, or many other medicines.

01 / PRACTICAL GUIDE

Dose, absorption, and combinations

These are indication-specific reference or studied ranges—not a personalized prescription. Start with the objective, then check the form, label, medicines, and health conditions.

Reference range by objective
Mood symptomsAbout 300 mg standardized extract three times daily in many trials

Reference or studied range—not a personalized prescription. The product label or a clinician may specify a different dose.

Dose source

More is not automatically better. A clinician or product label may specify a different amount.

Absorption / solubilityFormulation-dependent

Not usefully classified as a fat- or water-soluble vitamin; absorption depends on the salt, extract, delivery system, and meal.

How it is commonly taken

Use only a standardized product and clinician/pharmacist interaction review.

Do not combine casually

Do not combine with antidepressants, birth control, transplant, HIV, anticoagulant, seizure, cancer, or many other medicines.

Dose and use source

Dose and use links lead to primary or official source material. Search links are discovery tools, not proof that every returned paper applies.

02 / EVIDENCE

What the research says

We keep supportive, mixed, negative, safety, and contextual findings together. The headline never replaces the underlying papers.

2research papers in this ledger
35unique primary studies represented
6,993unique participants represented

These are audited counts for this JIVANA collection, not search-result totals. Participants are counted once when multiple papers use the same cohort; review papers are not added again to participant totals.

Open the research timelineResearch timeline

Entries are ordered by publication year. A study period appears only when the source reports it.

2016
Mixed or qualifiedPMID 27589952 · PROSPERO CRD42015016406

A systematic review of St. John's wort for major depressive disorder

St. John's wort produced more responders than placebo and similar outcomes to antidepressants in mild-to-moderate depression, with fewer reported adverse events. High heterogeneity, sparse severe-depression evidence, poor rare-event reporting, and extract differences constrain use.

Study design and methods
Design
Systematic review and meta-analysis of 35 randomized trials
Population
6,993 adults with major depressive disorder, mainly mild to moderate
Intervention
St. John's wort monotherapy for at least 4 weeks versus placebo or antidepressants
Outcome
Depression response, symptom scores, adverse events, and comparative effectiveness
Open research record
2016
Safety signalPMID 27444983

Co-administration of St. John's wort and hormonal contraceptives

Evidence showed more breakthrough bleeding, reduced hormone exposure, and a concern for ovulation and reduced contraceptive efficacy. This safety review is not added to efficacy study or participant totals.

Study design and methods
Design
Systematic review of 4 clinical or pharmacokinetic comparative studies
Population
Women of reproductive age using combined oral contraceptives
Intervention
Hormonal contraceptive with versus without St. John's wort
Outcome
Ovulation markers, breakthrough bleeding, and contraceptive hormone exposure

Funding or conflict note: CDC-supported review; authors declared no conflicts.

Open research record
Unscreened discovery appendix—not evidence86 candidate publicationsSearch run: Aug 21, 2026

Complete for the displayed PubMed query at the search timestamp—not for all databases or every possible synonym. Candidates can be irrelevant, duplicate the same study, or report negative findings. They are never summed as evidence or participants until screened.

03 / SOURCES

Start with the source material

The live search is for discovery only. Search-result counts change and are not included in the audited totals above.

Recent PubMed discovery recordsDirect links to the first 12 records returned by the reproducible search. These are discovery candidates—not reviewed summaries or a count of supportive findings.
  1. Efficacy of Pharmacological Interventions in Milder Depression: A Systematic Review and Meta-Analysis.Urata M, Sakurai H, Ueno F et al. · 2025 · Neuropsychopharmacology reports · PMID 40014460Open on PubMed
  2. The efficacy and safety of St. John's wort extract in depression therapy compared to SSRIs in adults: A meta-analysis of randomized clinical trials.Zhao X, Zhang H, Wu Y et al. · 2023 · Advances in clinical and experimental medicine : official organ Wroclaw Medical University · PMID 36226689Open on PubMed
  3. [Christmas article: Can gin with herbs induce the vision of Christmas elves?].Friesgaard KD, Fuglsang M, Aaboe ML et al. · 2022 · Ugeskrift for laeger · PMID 36510811Open on PubMed
  4. Antidepressants for smoking cessation.Howes S, Hartmann-Boyce J, Livingstone-Banks J et al. · 2020 · The Cochrane database of systematic reviews · PMID 32319681Open on PubMed
  5. The effect of Hypericum perforatum on postmenopausal symptoms and depression: A randomized controlled trial.Eatemadnia A, Ansari S, Abedi P et al. · 2019 · Complementary therapies in medicine · PMID 31331546Open on PubMed
  6. Subchronic treatment with St John's wort produces a positive shift in emotional processing in healthy volunteers.Warren MB, Cowen PJ, Harmer CJ · 2019 · Journal of psychopharmacology (Oxford, England) · PMID 30484733Open on PubMed
  7. Mineralocorticoid receptor-related markers and outcome of major depression: focus on blood pressure and electrolytes.Murck H, Ploch M, Montgomery S · 2018 · International clinical psychopharmacology · PMID 29489494Open on PubMed
  8. Comparative Benefits and Harms of Complementary and Alternative Medicine Therapies for Initial Treatment of Major Depressive Disorder: Systematic Review and Meta-Analysis.Asher GN, Gartlehner G, Gaynes BN et al. · 2017 · Journal of alternative and complementary medicine (New York, N.Y.) · PMID 28700248Open on PubMed
  9. Co-administration of St. John's wort and hormonal contraceptives: a systematic review.Berry-Bibee EN, Kim MJ, Tepper NK et al. · 2016 · Contraception · PMID 27444983Open on PubMed
  10. A systematic review of St. John's wort for major depressive disorder.Apaydin EA, Maher AR, Shanman R et al. · 2016 · Systematic reviews · PMID 27589952Open on PubMed
  11. Efficacy of Hypericum extract WS(®) 5570 compared with paroxetine in patients with a moderate major depressive episode - a subgroup analysis.Seifritz E, Hatzinger M, Holsboer-Trachsler E · 2016 · International journal of psychiatry in clinical practice · PMID 27161105Open on PubMed
  12. Association between physician beliefs regarding assigned treatment and clinical response: re-analysis of data from the Hypericum Depression Trial Study Group.Chen JA, Vijapura S, Papakostas GI et al. · 2015 · Asian journal of psychiatry · PMID 25544195Open on PubMed

04 / EXPERT CONTEXT

Expert context—not evidence

Expert positions are dated context—not scientific evidence. They never raise the evidence status or become consensus by repetition.

No direct, source-verified endorsement is currently recorded. Research authorship or discussion alone is not treated as endorsement.

Educational information only—not medical advice. Product quality, dose, medicines, pregnancy, and kidney or liver disease can materially change safety.